Adverse drug reactions.
Clearly, adverse drug reactions continue to induce injury and harm to patients, despite careful considerations, prescribing, dispensing, and administration. New drugs represent unknown risks and require intense scrutiny and monitoring in their early market stages. Deterioration of good monitoring, selection of more toxic drugs, and poor history taking from patients will continue to present challenges and increased risks from this partially reversible morbidity and mortality to patients.